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We designed a 48-well chemotaxis chamber to minimize manipulation time and 
amount of material required by the larger blindweli or Boyden chemotaxis chamber. Cell 
and ehemoattractant dose-response curves showed that results were comparable to or 
better than those obtained with blindwell chambers. The volume of chemoattractant per 
well is 25 pl; the number of cells can be as low as 10,000. The time needed for setting up 
this multiwell unit and for staining the membrane filter sheet is negligible. Combined with 
the use of an image analyzer to count the number of migrated cells, the method is suit- 
able for clinical research on the functional state of monocytes in large groups of patients. 
INTRODUCTION 
The first observat ion of  chemotax is  was reported by Leber  in 1888. Since 
that  t ime, there has been increasing interest in chemotax is  of  po lymorpho-  
nuclear leukocytes  and macrophages,  because a response to e laborat ion of  
chemotax ins  may account  for  leukocyte  accumulat ion at sites of  inf lamma- 
t ion. Chemotax is  has been studied in vitro on slides or coverslips (Comman-  
don,  1917; McCutcheon et al., 1934; Harris, 1953),  in capil lary tubes 
(Ketchel  and Favour,  1955),  in culture wells under  agarose (Cutler, 1974; 
Nelson et al., 1975; John  and Sieber, 1976) and by a membrane  fi lter tech- 
n ique first described by  Boyden in 1962. A l though the slide method is useful 
for  special ized studies such as the tracking of  individual leukocytes  (Grimes 
and Barnes, 1973; Z igmond and Hirsch, 1973),  Boyden 's  technique has the 
advantage of  s impl ic i ty and the potent ia l  for  providing quant i tat ive data. It  
has been used in several clinical studies that  have shown chemotax is  
abnormal i t ies  in disease. The Boyden chamber  consists of  an upper  and 
lower well separated by  a membrane  filter. Chemotact ic  solutions are placed 
in the lower well, cells are added to the top well, and after a per iod of  
incubat ion the cells that  have migrated toward  the chemotax in  are counted  
on the lower surface o f  the membrane .  Both chamber  and membrane  have 
been modi f ied by many investigators (Ward et al., 1965; Comely ,  1966; 
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Keller and Sorkin, 1968; Tempel et al., 1970; Wilkinson, 1974; Jungi, 1975; 
Campbell, 1977; Valerius, 1978). A blindwell version (Boumsell and Meltzer, 
1975) instead of the original Boyden chamber is now extensively used. 
However, despite modifications, the method is still too tedious and time 
consuming to allow handling of many samples. In addition to the space 
occupied in the incubator by the chambers, ample number is limited by the 
time required for assembling, disassembling, staining of individual membrane 
filters and washing of chambers. For clinical studies of chemotaxis and for 
increased accuracy, a simple method is needed which allows the processing 
of hundreds of samples. One step in this direction was made by Swanson 
(1977) who described a multichamber apparatus, consisting of 30 chambers 
in one unit. But it could not be used without centrifugation of the chamber 
and did not avoid the handling of single small filters. In this report, we 
describe results obtained with a newly designed 48-well chamber unit, con- 
sisting of top and bottom plates and a sealing gasket. Instead of multiple 
round filters, we use a single filter sheet. To conserve cells and chemotactic 
factor, the size of the wells has been reduced to a volume of 25 pl. The 
results are comparable to or better than those achieved with individual 
chambers, and assay time has been greatly reduced, due to manipulation of a 
single unit instead of 48 separate ones. 
MATERIALS AND METHODS 
Cell preparation 
Venous blood was drawn into heparinized syringes from healthy donors 
and mononuclear cells were isolated by the method of B~byum (1962). Total 
and differential counts were made for the final washed preparations. Differ- 
ential counts were made with a fluorescence microscope after staining cell 
suspensions with euchrysin 3Rx (Roboz Surgical Instruments Co., Washing- 
ton, DC}. Cell suspensions contained 15--35% monocytes, 65--85% lympho- 
cytes and less than 1% granulocytes. 
Chemotactic factors 
N-formylmethionyl-leucyl-phenylalanine-methylester (ref rr dto as pep- 
tide) was a generous gift of Dr. P.K. Ho (Lilly Co., Indianapolis). Human 
serum derived complement component C5a and lymphocyte derived chemo- 
tactic factor (LDCF) were prepared as described (Falk and Leonard, 1980). 
The pooled activity peak of a Sephadex G-100 fractionation of the crude 
factor was concentrated 10× by means of an immersible molecular separa- 
tion unit (Millipore Corp., Bedford, MA). 
Description of the chambers 
We constructed two kinds of multiwell chamber, one 24-well chamber 
with 200 pl per well volume and a 48-well chamber with 25 pl volume 
(Fig. 1). The single units of the 24-well chamber were exactly equivalent to 
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Fig. 1. Component parts of the 48-well micro chemotaxis chamber. Upper right: bottom 
plate with 48 wells of 25/21 volume each. The wells have raised rims to prevent spilling of 
chemotactic fluids from one well to another. The bolts are tapered to allow for exact 
positioning and easy assembling of the other components. A 7.6 cm × 2.5 cm Nucleopore 
filter sheet is placed on the filled wells. Middle: the silicon gasket, which is slipped over 
the bolts and placed on the filter. Lower left: the top plate, bottom side up. The 48 
holes (maximal volume 50 pl) have raised rims like the bottom wells. The top plate is 
pressed own by knurled nuts. The assembled apparatus i shown in Fig. 2. 
blindwell chambers and this set up was only used for compar ison with the 
blindwell chamber.  It will not  be discussed in detail. The 48-well chamber 
(Figs. 1 and 2) consists of  a bot tom plate with forty-eight 25 pl wells. A 
silicon gasket is used to obtain a perfect seal. The holes in the top plate 
become the top chambers after assembling. Nucleopore filter sheets of  5/am 
hole size and about  10 pm in thickness were placed between bot tom plate 
and gasket. The sheet size was 7.6 × 2.5 cm. The top and bot tom wells have 
slightly raised rims to eliminate any chance of movement  of  chemotact ic  
solutions f rom one well into another.  The distance between the wells is 
2 mm. The filter area used per single chamber  is 8 mm 2 and the ratio of  this 
area to the lower well volume is 1 : 3 in contrast  o 1 : 4 for the normal 200 
pl blindwell chamber.  Six threaded posts with knurled nuts are spaced along 
the edges of  the apparatus to supply an evenly distr ibuted pressure. No 
leakage was observed. The layout  of  the chamber  allows for duplicates, tripli- 
cates or quadruplicates. The experiments described in this paper were per- 
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Fig. 2. The assembled 48-well micro chemotaxis chamber. This is a photograph of the 
original prototype. Production models will be the same except for minor modifications. 
formed with a prototype chamber. Production chambers will be available 
from Neuro Probe. 
Chemotaxis  assay 
The assay with blindwell chambers was carried out as previously described 
(Falk and Leonard, 1980). Briefly, 200 pl of chemotactic solution was 
placed in the bottom wells and the top wells were filled with 0.3 ml of 
Gey's balanced salt solution containing 2% BSA (Gey's BSA) and 8 X 104 
monocytes. The two chambers were separated by a polycarbonate filter with 
5 tim holes (Nucleopore, Pleasanton, CA). The chambers were incubated for 
2 h at 37°C in humidified air with 5% CO2; the filters were removed, stained 
and the migrated cells were counted. 
The procedure for the multiwell chamber was similar. The bottom wells 
were filled with 25 pl of chemotactic solutions in Gey's BSA. Dilutions were 
prepared in microtiter plates. A filter sheet was then picked up by forceps 
and carefully placed on the bottom plate. Gasket and top plate were slipped 
over the threaded posts shown in Fig. 1 and bolted down. The monocyte 
suspension (30 pl) was added to the top chambers and the apparatus was 
incubated for 2 h. For removal of non-migrated cells from the top side of the 
filter at the end of the incubation, the chamber was disassembled and the 
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filter was suspended between 2 clamps. The filter was then drawn gently up 
the edge of  a windshield wiper blade. This was done twice, with immersion 
in phosphate-buffered saline between wipings. The filter was then fixed for 
about  2 min in methanol ,  mounted  on a glass slide and dried. The cells on the 
mounted  sheet were stained with Diff-Quick (Harleco, Gibbstown, NJ). 
Counting of  the migrated cells was done in different ways. Filters of  blind- 
well chambers were counted as previously described (Boetcher and Leonard, 
1974). Migrated cells on filter sheets were evaluated by means of  an 
Optomax Image analyzer (Optomax Inc., Hollis, NH). The area covered by 
migrated cells per selected field was measured. Five fields were sampled per 
replicate, with a 25X objective. In another  experiment,  with lower cell 
numbers,  a single 25X field per replicate was counted by eye. All assays were 
done in triplicate. All manipulat ions, including staining and washing the 
chamber  took  about  10 min. 
RESULTS 
Comparison with blindwell chambers 
Using the blindwell chamber  assay as a standard, we compared the dose 
responses of  human monocytes  to human C5a and chemotact ic  peptide in 
blindwell and 24-multiwell chambers. As shown in Fig. 3, the responses were 
not  significantly different. The slight differences een in the figures were not  
consistent. 
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Fig. 3. Comparison of dose responses of human monocytes to chemotactic peptide and 
human C5A in a blindwell and a multiwell chamber. A 24-well multichamber with the 
same dimensions as the blindwell chamber was used. The left panel shows the response to 
N-formyl-methionyl-leucyl-phenylalanine methylester. The right panel shows the response 
to human serum derived purified C5a. The same filter lot was used in both chambers. 
The error bars represent the standard error of the mean of triplicates. A relative concen- 
tration of 1 means a dilution of 1 : 6400 of the C5a stock solution. 
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Fig. 4. Dose  responses in a micro-mult iwel l  chamber of  human monocytes  to chemotaet ic  
pept ide and human C5a. The pept ide was N-formyl-methionyl - leucyl -phenyla lanine-  
methylester ;  C5a was prepared from human serum. The area covered by migrated cells 
was measured with an image analyzer; the area units are arbitrary. The error bars 
represent the standard error of the mean of triplicates. A relative concentrat ion of  
1 means a di lut ion of  1 : 6400  of the C5a stock solut ion.  The input monocyte  number 
per well  was 70 ,000 .  
The 48-well microchamber 
After  showing  that results with the 24-wel l  and individual bl indwel l  
chambers  were comparable ,  we  designed a 48-wel l  unit  with decreased wel l  
vo lumes  in order to  further reduce manipu lat ion  t ime and to conserve cells 
and chemotact i c  factors. The ef fect ive filter area o f  a b l indwel l  chamber  is 
about  50 mm 2, in contrast  to 8 for the microchamber .  We therefore were 
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Fig. 5. Dose response of  human monocytes  to human lymphocyte  derived chemotact ic  
factor in a micro-mult iwel l  chamber.  LDCF was prepared as described in Materials and 
Methods.  The error bars represent the standard error of  the mean of triplicates. One field 
per repl icate was counted by eye.  No error bar means that the standard error was smaller 
than the d imension of  the point.  Relat ive concentrat ion of  1 means a di lut ion of  I : 512 
of  the stock solut ion.  The input monocyte  number per well was 36 ,000 .  
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Fig. 6. Cel l -dose response  o f  human monocytes  in a micro -mul t iwe l l  chamber .  The  num-  
ber  o f  monocytes  added to the  upper  chamber  is shown on the  abscissa.  N - fo rmy l -  
meth iony l - leucy l -pheny la lan inemethy les ter  (10 -7 M) was used  as a t t rac tant .  The  insert  
represents  the  lower  part  o f  the  curve  on  a expanded scale. The  area un i t s  are a rb i t ra ry  
and  were determined  w i th  an image ana lyzer .  The  error  bars  represent  the  s tandard  e ror  
o f  the  mean o f  t r ip l icates.  No er ror  bar  means  that  the  s tandard  e ror  was  smal le r  than  
the  d imens ion  o f  the  po int .  
able to reduce the bottom well volume to 25 pl and the top well volume to 
30 pl. We also needed only 1/8 the number of cells to obtain the same cell 
density on the filter as for the blindwell chamber. The dose responses to 
peptide (Fig. 4, left panel), C5a (Fig. 4, right panel) and LDCF (Fig. 5) 
showed that the assay is sensitive to changes in concentration of chemotactic 
agents. The cell dose response (Fig. 6) showed the same wide range of linear- 
ity as we showed earlier for the blindwell chamber. The distribution of the 
cells was surprisingly homogeneous, in contrast to filters of blindwell 
chambers. In addition, variation among triplicates eemed to be less in the 
multiwell unit than with individual chambers. This may be due to the small 
size providing an equal microenvironment for all single chamber units during 
incubation. 
DISCUSSION 
Chemotaxis in vitro of leukocytes of man and experimental nimals is a 
widely used functional assay. One of its limitations has been the experi- 
mental procedure, which allowed the processing of only a limited number of 
samples. In this paper we describe a greatly improved procedure to measure 
chemotaxis. The various dose responses show the reliability of the assay. The 
system works as well for mouse macrophages (data not shown). 
The micro-multiwell chamber offers a number of important advantages 
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over other  chemotaxis  methods.  The t ime to per form a large assay is negligi- 
ble. The volume of chemotact ic  factor needed is very low {0.075 ml per 
tripl icate), and the cell number  needed per chamber can be as low as 10,000. 
We think in addit ion that  the small size and the therefore more uni form 
condit ions in the incubator make the use of triplicates unnecessary. This 
would further  decrease working and counting time. We know of only one 
published mult ichamber  assay (Swanson, 1977); but  it had disadvantages, 
such as the unexplained need for centr i fugation and the use of  single filters. 
I f  necessary, our  chambers can be centr i fuged in a Beckman TJ-6 centrifuge. 
The chamber is not  restr icted to the use of  Nucleopore filters; with modif ica- 
t ions cellulose filters or double fi lter techniques could also be used. 
To achieve this excel lent performance,  attent ion t  critical design details 
and high precision in construct ion were necessary. Special cutt ing tools of  
high quality were made. The lucite blocks were milled to provide small 
raised rims around each well to prevent movement  of  chemotact ic  factor 
solut ion f rom one well to another.  The 6 bolts were made not only to 
provide the tie downs, but  also a perfect  al ignment of top and bot tom wells. 
This was achieved by tapering. It is important  o treat the multiwell  chamber 
as a precision instrument in the general handling, rinsing and air drying of 
the component  parts. We recommend air drying at room temperature.  Oven 
drying or use of organic solvents may damage the materials. 
This assay system makes it possible to use chemotaxis as a clinical test, 
because 2--5 ml of  b lood are suff icient o do a large assay that includes dose- 
response curves to several d i f ferent chemotaxins in a short t ime. The other 
l imitat ion on the accumulat ion of  chemotaxis  data is the counting of  
migrated cells. Since this is t i resome and t ime consuming, some investigators 
have used radioactive labeling methods (Gallin et al., 1973; Papierniak et al., 
1976).  However,  fast and reliable count ing of  stained cells on or in 
chemotaxis  fi lters, w i thout  the addit ional step of  radioactive labeling, is now 
possible by the use of  image analyzers. With the Optomax analyzer, we 
counted cells by number  and by area covered by the cells. Both methods 
gave comparable results and are very fast. 
In summary,  the combined use of  our new micro-mult iwell  chamber and 
of  the image analyzer makes chemotaxis  a rapid and simple assay. We think 
that  it can now be used in the clinic to obtain in format ion about  the func- 
t ional state of  leukocytes.  
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